Companies: 10,795·Total market cap: $144.5T
VivoSim Labs, Inc.

VivoSim Labs, Inc.

VIVSNASDAQHealthcare● Active
$1.21
+$0.02(+1.68%)
Market Cap$3155632
P/E Ratio
52W High$5.3
52W Low$1.16

VivoSim Labs, Inc. (VIVS) Revenue

Annual & quarterly revenue history · segment & region breakdown

VIVS · revenue · updated Jun 9, 2026

Core revenue metrics

VivoSim Labs, Inc. trailing twelve-month (TTM) revenue is $0.00B, an increase of 0.00% year-over-year from — in FY.

TTM revenue
$0.00B
4-quarter sum · USD
YoY growth
+0.00%
vs FY
Price / sales
22.22×
mktCap ÷ TTM rev
Revenue per day
$0M
Est. TTM ÷ 365
Revenue / employee
$10K
14 employees
FY
FY
5Y CAGR
Fiscal year end
Dec 31
Currency
USD · GAAP
Filing
10-K / 10-Q
Source: FMP · VivoSim Labs, Inc. SEC filings · GAAPUpdated: 2026-06-09

Revenue trend

· Annual
YoY revenue growth %
revenue trend · revenue chart · revenue by year · revenue history

Revenue history

Fiscal year endRevenueChangeGrowth
VIVS revenue by year · VIVS revenue history · VIVS annual revenue data

About Revenue & Reporting

Revenue (also called sales, net sales, or turnover) is the total income VivoSim Labs, Inc. receives from its business operations before deducting any costs or expenses. It is the top line of the income statement. Unlike net income or earnings, revenue does not account for operating costs, taxes, interest, or depreciation.

VivoSim Labs, Inc. reports revenue on a fiscal year ending Dec 31 basis under US GAAP, denominated in USD.

Data sourced from VivoSim Labs, Inc.'s 10-K and 10-Q SEC filings via Financial Modeling Prep.

Figures tie to SEC 10-K/10-Q and FMP income-statement endpoints where noted.

Frequently asked questions

VIVS revenue · 4 questions

VIVS's trailing twelve-month (TTM) revenue is $0.00B. That is an increase of 0.00% year-over-year from — in FY.

VIVS revenueVIVS annual revenuewhat is VIVS revenueVIVS TTM revenue

Source: FMP · VivoSim Labs, Inc. SEC filings · GAAP · VivoSim Labs, Inc. SEC 10-K & 10-Q filings · US GAAP · Updated: Jun 9, 2026